Reliability and Validity Study of Urdu Version of Oxford Knee Score in Patients With Knee Osteoarthritis


Riphah International University




Knee Osteoarthritis

Study type


Funder types




Details and patient eligibility


To translate the Oxford knee score into Urdu language To evaluate the reliability and validity of Urdu Version of Oxford knee score for accessing pain and physical function in patients with knee osteoarthritis. To evaluate the correlation of Oxford knee score with Western Ontario McMaster universities osteoarthritis index and International Knee Documentation Committee

Full description

The original English version of Oxford Knee Score will be translated and culturally adapted as per previous recommendation. In patients with knee osteoarthritis, Urdu Version of Oxford Knee Score will be distributed among 100 participants choose a convenience sampling technique based on pre-defined inclusion and exclusion criteria. To test reliability of inter/intra observer of ultimate final Urdu Version of Oxford Knee Score will be filled from patients on the equivalent day, by 2 different bystanders, and for inter observer valuation, with an interval of 30 minutes between the first and second application. Third assessment will be carried out after 7 days of the Observer -1, for intra-observer assessment. Data will be entered and analyzed Cronbach alpha value. Test-retest reliability will be assessed using an intra-class correlation coefficient. Urdu Version of Oxford Knee Score will be evaluated for content validity, construct validity, criterion validity and responsiveness.


100 patients




35 to 80 years old


No Healthy Volunteers

Inclusion criteria

  • Diagnosed knee Osteoarthritis patients were included
  • Both male and female patients were included
  • Both unilateral and bilateral knee Osteoarthritis patients were included
  • Patients were included who fulfilled the American college of rheumatology criteria
  • Patients were included between the age of 35-80 Y old patients

Exclusion criteria

  • Patients with any heart problem were excluded
  • Patients with peripheral vascular injury were excluded

Trial contacts and locations



Central trial contact

Muhammad Kashif

Data sourced from

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems